- Home
- SABS vs PLAG Comparison
SABS vs PLAG Comparison
Compare SABS & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- PLAG
- Stock Information
- Founded
- SABS 2014
- PLAG 1986
- Country
- SABS United States
- PLAG United States
- Employees
- SABS N/A
- PLAG N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- PLAG Packaged Foods
- Sector
- SABS Health Care
- PLAG Consumer Staples
- Exchange
- SABS Nasdaq
- PLAG Nasdaq
- Market Cap
- SABS 11.4M
- PLAG 10.0M
- IPO Year
- SABS N/A
- PLAG N/A
- Fundamental
- Price
- SABS $1.75
- PLAG $1.29
- Analyst Decision
- SABS Strong Buy
- PLAG
- Analyst Count
- SABS 5
- PLAG 0
- Target Price
- SABS $11.40
- PLAG N/A
- AVG Volume (30 Days)
- SABS 25.4K
- PLAG 137.4K
- Earning Date
- SABS 05-19-2025
- PLAG 05-14-2025
- Dividend Yield
- SABS N/A
- PLAG N/A
- EPS Growth
- SABS N/A
- PLAG N/A
- EPS
- SABS N/A
- PLAG N/A
- Revenue
- SABS $1,322,410.00
- PLAG $6,729,937.00
- Revenue This Year
- SABS N/A
- PLAG N/A
- Revenue Next Year
- SABS $50.00
- PLAG N/A
- P/E Ratio
- SABS N/A
- PLAG N/A
- Revenue Growth
- SABS N/A
- PLAG N/A
- 52 Week Low
- SABS $1.00
- PLAG $1.00
- 52 Week High
- SABS $5.01
- PLAG $5.52
- Technical
- Relative Strength Index (RSI)
- SABS 63.35
- PLAG 44.08
- Support Level
- SABS $1.30
- PLAG $1.20
- Resistance Level
- SABS $1.49
- PLAG $1.76
- Average True Range (ATR)
- SABS 0.14
- PLAG 0.25
- MACD
- SABS 0.06
- PLAG 0.03
- Stochastic Oscillator
- SABS 100.00
- PLAG 36.49
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.